1.de Laszlo SE, Visco D, Agarwal L, Chang L, Chin J, Croft G, Forsyth A, Fletcher D, Frantz B, Hacker C, Hanlon W, Harper C, Kostura M, Li B, Luell S, MacCoss M, Mantlo N, O'Neill EA, Orevillo C, Pang M, Parsons J, Rolando A, Sahly Y, Sidler K, O'Keefe SJ.. (1998) Pyrroles and other heterocycles as inhibitors of p38 kinase., 8 (19):[PMID:9873604][10.1016/s0960-894x(98)00495-8]
2.de Laszlo SE, Hacker C, Li B, Kim D, MacCoss M, Mantlo N, Pivnichny JV, Colwell L, Koch GE, Cascieri MA, Hagmann WK.. (1999) Potent, orally absorbed glucagon receptor antagonists., 9 (5):[PMID:10201821][10.1016/s0960-894x(99)00081-5]
3.Wang N, DeLisle RK, Diller DJ.. (2005) Fast small molecule similarity searching with multiple alignment profiles of molecules represented in one-dimension., 48 (22):[PMID:16250656][10.1021/jm050563r]
4.Shahlaei M, Nazari Z. (2013) Computational neural network analysis of the affinity of 2-pyridyl-3,5-diaryl pyrroles analogs for the human glucagon receptor using density functional theory, [10.1007/s00044-013-0801-3]